These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8524695)

  • 21. Reduced production, absorption, and elimination of erythropoietin in uremia compared with healthy volunteers.
    Jensen JD; Madsen JK; Jensen LW; Pedersen EB
    J Am Soc Nephrol; 1994 Aug; 5(2):177-85. PubMed ID: 7993997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal proteins and chronic treatment with low-dose erythropoietin.
    Bellizzi V; de Nicola L; Ames P; Libertino R; Terracciano V; Cianciaruso B
    J Lab Clin Med; 1997 Feb; 129(2):193-9. PubMed ID: 9016855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How the duration period of erythropoietin treatment influences the oxidative status of hemodialysis patients.
    Dimitrijevic ZM; Cvetkovic TP; Djordjevic VM; Pavlovic DD; Stefanovic NZ; Stojanovic IR; Paunovic GJ; Velickovic-Radovanovic RM
    Int J Med Sci; 2012; 9(9):808-15. PubMed ID: 23136545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
    Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
    Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of recombinant human erythropoietin (rh-EPO) in the treatment of anemia in hemodialysis patients: a multicenter Italian experience.
    Buccianti G; Colombi L; Battistel V
    Haematologica; 1993; 78(2):111-7. PubMed ID: 8349186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of long-term erythropoietin (rHuEPO) therapy on the function of the pituitary-gonadal axis in hemodialyzed male patients with end stage renal failure].
    Trembecki J; Kokot F; Wiecek A; Marcinkowski W; Rudka R
    Pol Arch Med Wewn; 1995 Aug; 94(2):144-52. PubMed ID: 8596749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peritoneal dialysis adequacy during the r-Hu EPO treatment.
    Baranowska-Daca E; Ksiazek A
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():51-60. PubMed ID: 8192532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of recombinant human erythropoietin on hemostatic status in chronic uremic patients.
    Tsao CJ; Kao RH; Cheng TY; Huang CC; Chang SL; Lee FN
    Int J Hematol; 1992 Apr; 55(2):197-203. PubMed ID: 1511168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
    Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
    ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term erythropoietin therapy does not affect metalloproteinases and their inhibitor levels, oxidative stress and inflammation in hemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Am J Nephrol; 2007; 27(3):221-5. PubMed ID: 17384500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
    Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
    Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction of deficient phagocytosis during erythropoietin treatment in maintenance hemodialysis patients.
    Veys N; Vanholder R; Ringoir S
    Am J Kidney Dis; 1992 Apr; 19(4):358-63. PubMed ID: 1562025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of recombinant human erythropoietin on plasma von Willebrand factor in chronic hemodialysis patients.
    Hársfalvi J; Boda Z; Mikita J; Kárpáti I; Kakuk G; Rák K
    Am J Hematol; 1994 Oct; 47(2):144-5. PubMed ID: 8092134
    [No Abstract]   [Full Text] [Related]  

  • 35. [Does erythropoietin treatment influence the lipid status of patients on maintenance hemodialysis?].
    Król E; Debska-Slizień A; Biedunkiewicz B; Zdrojewski Z; Wróblewska M; Rutkowski B
    Pol Arch Med Wewn; 1995 Nov; 94(5):410-7. PubMed ID: 8833938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of the treatment with human recombinant erythropoietin on primary hemostasis in uremic patients].
    Cases A; Escolar G; Reverter JC; Garrido M; Ordinas A; López-Pedret J; Castillo R; Revert L
    Med Clin (Barc); 1990 Nov; 95(17):644-7. PubMed ID: 2089202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocyte PC-1 activity in patients on maintenance haemodialysis treated with human erythropoietin and 1-alpha-D3.
    Stefanovic V; Djordjevic V; Ivic M; Mitic-Zlatkovic M; Vlahovic P
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):55-60. PubMed ID: 15802034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of cytokines in the response to erythropoietin in hemodialysis patients.
    Goicoechea M; Martin J; de Sequera P; Quiroga JA; Ortiz A; Carreño V; Caramelo C
    Kidney Int; 1998 Oct; 54(4):1337-43. PubMed ID: 9767553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interpatient variation in response to subcutaneous versus intravenous low dose erythropoietin.
    Barclay PG; Fischer ER; Harris DC
    Clin Nephrol; 1993 Nov; 40(5):277-80. PubMed ID: 8281716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of human recombinant erythropoietin (r-EPO) on behavior of iron status parameters in patients with chronic renal failure treated with dialysis].
    Debska-Slizień A; Biedunkiewicz B; Rutkowski B
    Pol Arch Med Wewn; 1994 Sep; 92(3):207-15. PubMed ID: 7808929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.